Methyl 2-bromo-3-methylbutanoate

We are Methyl 2-bromo-3-methylbutanoate CAS:26330-51-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  Methyl 2-bromo-3-methylbutanoate
CAS.NO:26330-51-8
Synonyms: Methyl 2-bromo-3-methylbutanoate
methyl 2-bromo-3-methylbutyrate
methyl 2-bromo-3-methylbutanoic ester
Butanoic acid, 2-bromo-3-methyl-, methyl ester
Methyl 2-bromoisovalerate
 
Molecular Formula:C6H11BrO2
Molecular Weight: 195.05400
 
Physical and Chemical Properties:
Density:1.345 g/cm3
Boiling point:173ºC
Melting point:/
Flash point:60.8ºC
Index of Refraction:1.454
 
Specification:
Appearance:Colorless liquid
Purity:≥99.0%
 
Packing:25kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, dry place. Keep container closed when not in use.
Application:For organic synthesis intermediates, refrigerants, etc.

Methyl 2-bromo-3-methylbutanoate


Related News: The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.2,3-Dihydrobenzo[b]furan-5-carbaldehyde CAS:55745-70-5 There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.120-61-6 The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).872-06-0 Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed.

Related Products
Product Name
Disodium uridine-5′-monophosphate View Details
(2S)-2-(butylsulfonylamino)-3-(4-hydroxyphenyl)propanoic acid View Details
1-Chlorobutane View Details
N2-(1-Oxohexadecyl)-L-lysyl-L-valyl-L-lysine 2,2,2-trifluoroacetate manufacturer methimazole manufacturer CAS:37859-57-7 Methyltris(methylisobutylketoxime)silane manufacturer 4-octylbenzoic acid manufacturer 2,3,4,5-Tetrafluorobenzoic acid manufacturer